Literature DB >> 18568517

Correlating the cochleovestibular deficits with tumor size of acoustic neuroma.

An-Shiou Day1, Chi-Te Wang, Chun-Nan Chen, Yi-Ho Young.   

Abstract

CONCLUSION: The tumor size of acoustic neuroma correlates with cochleovestibular deficits. Those tumors with global frequency hearing loss, bilateral gaze nystagmus, or absent caloric and VEMP responses may indicate a tumor size >2.5 cm.
OBJECTIVE: This study aimed to investigate the correlation between cochleovestibular deficits and the size of acoustic neuroma. PATIENTS AND METHODS: A total of 44 patients with acoustic neuroma were enrolled in this study. Pure tone audiometry, electronystagmography, caloric test, vestibular evoked myogenic potential (VEMP) test, and MRI were conducted.
RESULTS: There is a trend of correlation between tumor size and audiographic configuration, with small-sized tumor in normal and rising types, medium-sized tumor in mid- and high-frequency hearing loss, and large-sized tumor in flat and deafness types. Five patients with bilateral gaze nystagmus had significantly larger tumor size than those without nystagmus. When 1 and 0 are used to represent abnormal and normal responses, respectively, the relationship between tumor size and vestibular function can be expressed as: tumor size (cm)=1.43 (caloric response)+1.35 (VEMP response), indicating that the estimated tumor size for those with abnormal caloric or VEMP responses increased by 1.43 or 1.35 cm, respectively.

Entities:  

Mesh:

Year:  2008        PMID: 18568517     DOI: 10.1080/00016480701749240

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  14 in total

Review 1.  Vestibular-evoked myogenic potentials eliciting: an overview.

Authors:  Anna Eleftheriadou; Eleftherios Koudounarakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-10-21       Impact factor: 2.503

2.  [Video head impulse test or caloric irrigation?. Contemporary diagnostic tests for vestibular schwannoma].

Authors:  A Blödow; R Helbig; N Wichmann; A Wenzel; L E Walther; M B Bloching
Journal:  HNO       Date:  2013-09       Impact factor: 1.284

3.  Adaptation of vestibular tone studied with electrical stimulation of semicircular canal afferents.

Authors:  Richard F Lewis; Keyvan Nicoucar; Wangsong Gong; Csilla Haburcakova; Daniel M Merfeld
Journal:  J Assoc Res Otolaryngol       Date:  2013-02-20

4.  Vestibular assessment in patients with vestibular schwannomas: what really matters?

Authors:  R Teggi; A Franzin; G Spatola; N Boari; P Picozzi; M Bailo; L O Piccioni; F Gagliardi; P Mortini; M Bussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-04       Impact factor: 2.124

5.  Auditory Pathway Features Determined by DTI in Subjects with Unilateral Acoustic Neuroma.

Authors:  S Kurtcan; A Alkan; R Kilicarslan; A A Bakan; H Toprak; A Aralasmak; F Aksoy; A Kocer
Journal:  Clin Neuroradiol       Date:  2015-03-27       Impact factor: 3.649

6.  Large and small vestibular schwannomas: same, yet different tumors.

Authors:  Satoshi Kiyofuji; Brian A Neff; Matthew L Carlson; Colin L W Driscoll; Michael J Link
Journal:  Acta Neurochir (Wien)       Date:  2021-01-20       Impact factor: 2.216

7.  Audiological correlates of tumor parameters in acoustic neuromas.

Authors:  Hakan Tutar; Mehmet Duzlu; Nebil Göksu; Selin Ustün; Yıldırım Bayazit
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-02-10       Impact factor: 2.503

Review 8.  Evaluation of Vestibular Function in Diagnosis of Vestibular Schwannomas.

Authors:  Xue-Qing Zhang; Tai-Sheng Chen; Wei Wang
Journal:  Curr Med Sci       Date:  2021-08-17

9.  Audiological findings in a case of cerebellar angioreticuloma.

Authors:  A Serra; P DI Mauro; S Cocuzza; I Chiaramonte; L Maiolino
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-06       Impact factor: 2.124

10.  Bilateral Vestibular Hypofunction: Insights in Etiologies, Clinical Subtypes, and Diagnostics.

Authors:  F Lucieer; P Vonk; N Guinand; R Stokroos; H Kingma; Raymond van de Berg
Journal:  Front Neurol       Date:  2016-03-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.